Skip to main content
logo
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
26.24
+0.75 (2.94%)
At close: Aug 19, 2026, 4:00 PM EDT
28.68
+2.44 (9.30%)
Pre-market: Aug 20, 2026, 7:34 AM EDT

Ultragenyx Pharmaceutical Revenue by Segment

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Product
397.99M366.81M369.31M339.18M321.49M314.47M285.47M265.30M
Product Growth
23.80%16.64%29.37%27.85%39.59%58.26%58.24%68.34%
Other
318.94M302.62M303.42M291.43M288.69M276.21M274.71M257.40M
Other Growth
10.48%9.56%10.45%13.22%15.06%13.29%8.24%1.90%

Revenue by Geography

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
North America
396.28M378.21M377.00M361.22M354.58M340.56M340.46M316.40M
North America Growth
11.76%11.06%10.73%14.16%15.39%14.40%10.86%5.82%
Latin America
175.15M157.11M170.00M149.83M144.47M150.40M130.71M130.30M
Latin America Growth
21.23%4.46%30.06%14.99%31.93%67.67%69.10%93.32%
Europe
124.27M115.67M108.00M103.33M97.65M87.45M80.12M69.60M
Europe Growth
27.26%32.27%34.79%48.47%61.68%61.35%68.33%63.00%
Japan
21.52M18.72M18.00M12.64M9.79M8.69M5.40M6.40M
Japan Growth
119.88%115.49%233.33%97.48%138.66%768.50%145.45%433.33%